Treatment of thrombotic thrombocytopenic purpura with plasma.
about
Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpuraVon Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpuraThrombotic thrombocytopenic purpura with terminal pancytopeniaThrombotic thrombocytopenic purpura today.Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood.Management of thrombotic thrombocytopenic purpura.Cryoprecipitate-reduced plasma:rationale for use and efficacy in the treatment of thrombotic thrombocytopenic purpura.Thrombotic thrombocytopenic purpura: survival by "giving a dam"Thrombotic microangiopathies: an update.Myocardial infarction in thrombotic thrombocytopenic purpura: a single-center experience and literature review.Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura.Therapeutic apheresis: history, clinical application, and lingering uncertainties.Peripartum haemolytic uraemic syndrome complicating pregnancy.Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies.Investigational drugs in thrombotic thrombocytopenic purpura.Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.Plasma therapy for severe hemolytic-uremic syndrome in children in Atlantic Canada.Plasma exchange for renal disease: evidence and use 2011.Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.Thrombotic Thrombocytopenic Purpura: Pathogenesis, Diagnosis, and Potential Novel Therapeutics.Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome.Prolonged and profound fatigue in a young man.Haemolytic uraemic syndrome: therapeutic effect of plasma infusionPlasma infusions in thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus--a successful outcome.Treatment of thrombotic thrombocytopenic purpura with plasma exchange, antiplatelet agents, corticosteroid, and plasma infusion: Mayo Clinic experience.Accessible plasma exchange using membrane filter - a successfully treated case of TTP with repeated plasma exchanges.Simultaneous hemodialysis and exchange transfusion in hemolytic uremic syndrome.Thrombotic thrombocytopenic purpura plasma enhances platelet-leucocyte interaction in vitro.Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group.Abuse of fresh frozen plasma.Indications for therapeutic plasma exchange at a university hospital and a regional blood center.Thrombotic microangiopathy in haematopoietic cell transplantation: an update.Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach.Therapeutic plasmapheresis and plasma exchange.Indications for emergency apheresis procedures.Plasma exchange and plasmapheresis.Membrane cascade plasmapheresis: theoretical analysis and in vitro studies.Current Clinical Practice: Current Management of Thrombotic Thrombocytopenic Purpura.Prostacyclin deficiency in haemolytic-uraemic syndrome.
P2860
Q24241470-9EAD5D0B-7545-4E03-BF08-58A20A695398Q24651320-C822BC4F-746B-4D28-B62A-C3F6887821B7Q27486371-767C5168-2826-495D-9F8F-D919C3C794BDQ33329549-944C1364-CE48-491A-987F-13D43A812E8AQ33330536-DBF6FFCF-007C-428F-B9C9-380248B3F49CQ33333063-FAE38823-AED7-4C19-9F80-05EECA131AF6Q33337694-2A477F9A-5555-4975-BDE6-901AE6ACE3BAQ33373067-AE136F9C-9F3A-496B-98F0-5361D10C7092Q33374370-F0EE1B84-4D99-4DEB-86AA-19A1C48ACF9CQ33380292-99A975C4-FADD-43E6-930D-879A95E67D65Q33383236-BA83E0D6-6559-4ED6-A24B-97BE2B3204CEQ33387254-78705050-8BD1-443E-850D-1BCA54D4C0AAQ33393926-3F356B90-14BC-4513-B039-6AAEAACEDD66Q33393992-ECF4593F-98D3-41E7-AE8D-17561273E3DBQ33395696-0FC81CBA-4B6C-488E-BB86-2B6A887803FDQ33399520-BA0FD030-CB17-4F6D-A777-BB46EBB68499Q33400903-4B49781B-EAE1-477D-B00E-167E5B0F9B64Q33400941-157B1BC0-9D0B-4BF8-8E60-25E8AAD9BDA9Q33416588-28BB4320-BB7E-4EB3-8AB7-82EC991D676AQ33443111-0368D01A-CB65-41D7-BC34-2E98B94F3685Q33477382-FE6E036C-EB88-40EA-8CA9-B96350019900Q33477966-406C77AB-36BB-4593-9D0E-11940FD3F5E2Q33481815-562D1C92-89D3-4BAF-9BA9-A206CF45579AQ33482490-DDE60BB1-15CD-4F69-A41F-98D8C7DFD6D1Q33482785-429496E7-1B1C-408F-917D-4720BC05914AQ33485660-E6BF6E2F-DDB1-456E-A9AE-0CC77AF869BCQ33487021-E652523F-8762-4883-8A64-9F22108BF681Q33501513-F4E7D1B9-C0A2-44B0-9D65-547BA6EEAED1Q33504909-DD292AC6-4D36-41A9-855E-51030329EE19Q34071224-9AD6A2C3-6000-480B-B6B2-37767AC86867Q34109833-541CB16C-5E83-4CEC-BB7E-BFA9FC4610CDQ35098992-0C90D09D-D50A-4F3D-BC89-0F09E14BBE81Q37820338-158F1CF6-14A2-4FAE-B92A-F70D70169F34Q39587536-73C2ACB4-0E42-4D07-9B40-0FB0BCEC4DDCQ41687664-A71B2CDD-2F2E-4B1E-A710-881324C1915FQ42927458-776403C9-77D6-485A-83F4-AE81109FCEF9Q52698376-1B0871CA-41B2-47FD-B9CF-0902A4D39C7EQ54394972-2EC94C84-A837-4152-9869-8F0F3F0E9D9AQ55563939-EB98CD68-977E-492E-9EB4-063650E669C2
P2860
Treatment of thrombotic thrombocytopenic purpura with plasma.
description
1977 nî lūn-bûn
@nan
1977 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Treatment of thrombotic thrombocytopenic purpura with plasma.
@ast
Treatment of thrombotic thrombocytopenic purpura with plasma.
@en
type
label
Treatment of thrombotic thrombocytopenic purpura with plasma.
@ast
Treatment of thrombotic thrombocytopenic purpura with plasma.
@en
prefLabel
Treatment of thrombotic thrombocytopenic purpura with plasma.
@ast
Treatment of thrombotic thrombocytopenic purpura with plasma.
@en
P1476
Treatment of thrombotic thrombocytopenic purpura with plasma.
@en
P2093
P304
P356
10.1056/NEJM197712222972507
P407
P577
1977-12-01T00:00:00Z